Physician profile
Wanda Bronstein
NPI 1053689489
$1,173.77
in general payments reported to CMS, 2019-2025
21 companies · $806 in 2025
The $806 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $328 · 2023: $23.73 · 2024: $15.83 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.57 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $229.39 | 2025 | Tremfya |
| Incyte Corporation | $86.52 | 2022-2025 | Opzelura |
| Lilly USA, LLC | $82.96 | 2025 | Ebglyss, Taltz |
| Takeda Pharmaceuticals U.S.A., INC. | $77.25 | 2022 | |
| Abbvie INC. | $73.19 | 2022-2025 | |
| Intercept Pharmaceuticals, INC. | $69.12 | 2022 | |
| Amgen INC. | $65.21 | 2025 | Otezla |
| Ucb, INC. | $62.58 | 2025 | Bimzelx |
| Galderma Laboratories, L.P. | $62.27 | 2025 | Nemluvio |
| Sun Pharmaceutical Industries INC. | $51.25 | 2025 | |
| Celgene Corporation | $46.45 | 2022-2023 | Zeposia |
| Leo Pharma INC. | $46.12 | 2025 | Adbry |
| Ardelyx, INC. | $43.38 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.69 | 2025 | Cabtreo |
| Gilead Sciences, INC. | $27.79 | 2022-2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $23.11 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $22.97 | 2025 | Sotyktu |
| Genzyme Corporation | $21.10 | 2025 | |
| Novartis Pharmaceuticals Corporation | $19.80 | 2022 | |
| Glaxosmithkline, LLC. | $15.64 | 2022 | |
| Redhill Biopharma INC. | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanda Bronstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.